# CyPath Lung

Type: Product

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/cypath-lung-product
Canonical HTML page: https://getfinancebrief.com/entity/cypath-lung-product

## Recent coverage (1 stories)

### BIAF Up 47.95% Post-Reverse Split, But Cash Drops to $2.4M
2026-09-05 14:59:24 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A 1-for-15 reverse split and a surveillance announcement produced a 47.95% one-day jump for thinly traded bioAffinity Technologies. But only $2.4 million in cash and a warrant overhang complicate the move's sustainability.
Full story: https://getfinancebrief.com/story/biaf-reverse-split-47-percent-jump-finance

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.